ArticleInfluenza and other respiratory viruses2025
Demographic Analysis of Mortality Changes Associated With the COVID-19 Pandemic in Japan, 2020-2022.
Article in Influenza and other respiratory viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundsDemographic analysis is required to thoroughly evaluate the mortality impact of COVID-19 in Japan that cannot be captured by epidemiological surveillance.
methodsA hierarchical time-varying regression model was applied to prefectural life table data in Japan during 2000-2019. Pre-pandemic baseline mortality rates and death counts during 2020-2022 were projected by this model to evaluate the mortality impact of the COVID-19 pandemic on mortality during 2020-2022.
resultsNationally, the observed mortality rates were higher than projected rates among those aged 10-29 years and lower for ages 1-9 and > 80 years in 2020. During 2021 and 2022, mortality rates consistently increased for most age groups, with substantial regional heterogeneity in those aged < 14 years. Consistently, the neutral gaps between the observed and projected life expectancy across prefectures in 2020 turned negative in most prefectures during 2022. In 2022, the negative gap in life expectancy ranged from a substantial shortening of -1.50 years (95% prediction interval [PI]: -1.82, -1.16) in Okinawa to a slight shortening of -0.21 years (95% PI: -0.65, 0.22) in Tottori. Excess deaths per population also grew consistently in all prefectures during 2020-2022; Miyazaki yielded the largest estimate at 177.4 (95% PI: 144.9, 210.2) per 100,000 population.
conclusionsOur framework highlights the usefulness of life table data for evaluating the mortality impact caused by an event such as the pandemic. Our estimates, adjusted by pre-pandemic demographic trends, revealed the massive mortality impact of the COVID-19 pandemic across a wide age range.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.